Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asclepius Meditec is a leading medical technology company focused on the clinical application of hydrogen-oxygen gas mixtures. The company developed the world's first Class III medical device for hydrogen-oxygen inhalation, which is primarily indicated for the treatment of respiratory conditions such as COPD and asthma. Their technology leverages the selective antioxidant properties of hydrogen to reduce inflammation and oxidative stress in patients. Beyond respiratory health, Asclepius is exploring the use of hydrogen therapy in oncology, neurology, and rehabilitation. The company's products were notably included in China's national treatment protocols for COVID-19.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 潓美医疗科技.